Complementary role of HCV and HIV in T-cell activation and exhaustion in HIV/HCV coinfection

PLoS One. 2013;8(3):e59302. doi: 10.1371/journal.pone.0059302. Epub 2013 Mar 15.

Abstract

Objectives: To investigate whether T-cell activation and exhaustion is linked to HCV- and HIV disease parameters in HIV/HCV infected individuals, we studied T-cell characteristics in HIV/HCV coinfected patients and controls.

Methods: 14 HIV/HCV coinfected, 19 HCV monoinfected, 10 HIV monoinfected patients and 15 healthy controls were included in this cross-sectional study. Differences in expression of activation and exhaustion markers (HLA-DR, CD38, PD-1, Tim-3 and Fas) and phenotypic markers on CD4(+) and CD8(+) T-cells were analysed by flow cytometry and were related to HCV disease parameters (HCV-viremia, ALT and liver fibrosis).

Results: Frequencies of activated CD4(+) and CD8(+) T-cells were higher in HIV/HCV-coinfected compared to healthy controls and HCV or HIV mono-infected individuals. Coinfected patients also showed high expression of the exhaustion marker PD-1 and death receptor Fas. In contrast, the exhaustion marker Tim-3 was only elevated in HIV-monoinfected patients. T-cell activation and exhaustion were correlated with HCV-RNA, suggesting that viral antigen influences T-cell activation and exhaustion. Interestingly, increased percentages of effector CD8(+) T-cells were found in patients with severe (F3-F4) liver fibrosis compared to those with no to minimal fibrosis (F0-F2).

Conclusions: HIV/HCV coinfected patients display a high level of T-cell activation and exhaustion in the peripheral blood. Our data suggest that T-cell activation and exhaustion are influenced by the level of HCV viremia. Furthermore, high percentages of cytotoxic/effector CD8(+) T-cells are associated with liver fibrosis in both HCV monoinfected and HIV/HCV coinfected patients.

MeSH terms

  • Adult
  • Antigens, CD / genetics
  • Antigens, CD / immunology
  • Biomarkers / metabolism
  • CD4-Positive T-Lymphocytes / immunology
  • CD4-Positive T-Lymphocytes / pathology
  • CD4-Positive T-Lymphocytes / virology*
  • CD8-Positive T-Lymphocytes / immunology
  • CD8-Positive T-Lymphocytes / pathology
  • CD8-Positive T-Lymphocytes / virology*
  • Case-Control Studies
  • Coinfection
  • Cross-Sectional Studies
  • Female
  • Fibrosis
  • Gene Expression
  • HIV Infections / immunology
  • HIV Infections / pathology
  • HIV Infections / virology*
  • HIV-1 / immunology*
  • HLA-DR Antigens / genetics
  • HLA-DR Antigens / immunology
  • Hepacivirus / immunology*
  • Hepatitis C / immunology
  • Hepatitis C / pathology
  • Hepatitis C / virology*
  • Humans
  • Liver / pathology
  • Liver / virology
  • Lymphocyte Activation*
  • Male
  • Middle Aged

Substances

  • Antigens, CD
  • Biomarkers
  • HLA-DR Antigens

Grants and funding

The authors have no support or funding to report.